Similarly, in ccRCC tumor cells with pVHL missense mutations, OTUD6B inhibited ccRCC migration by regulating pVHL/HIF-2α; low levels of OTUD6B predicted a higher pathological stage and shorter OS in ccRCC patients [94] (Fig. 7). This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.